TRUQAP
Identification of Truqap
No description |
Google image searchProduct monograph
Active ingredient
capivasertib, 200 MG
DIN: 02544741
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: ASTRAZENECA CANADA INC
Date: 01-APR-2024
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
- L01EX — Other protein kinase inhibitors (ATC, ATC/DDD)
- L01EX27 — CAPIVASERTIB (ATC/DDD)
External Links for Truqap
Search on Google
Astrazeneca Canada Inc
Go to AstraZeneca website to see drug product details. Sometimes you can find truqap photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.